Background: Brain metastases frequently occur in patients with non-small cell lung cancer (NSCLC) resulting in a poor prognosis. Here, we investigated the association between PD-L1 expression and brain metastasis in patients with NSCLC and its clinical significance. Methods: A total of 270 patients diagnosed with metastatic NSCLC who underwent PD-L1 testing on their tumor tissue between January 2017 and March 2019 were retrospectively reviewed. The VENTANA PD-L1 (SP263) assay was used, and positive PD-L1 expression was defined as staining in ≥1% of tumor cells. Results: Positive PD-L1 expression was observed in 181 (67.0%) patients, and 74 (27.4%) patients had brain metastasis at diagnosis. Synchronous brain metastases were more frequently observed in PD-L1-positive compared with PD-L1-negative patients (31.5% vs. 19.1%, p = 0.045). Multiple logistic regression analysis identified positive PD-L1 expression (odds ratio [OR]: 2.24, p = 0.012) as an independent factor associated with synchronous brain metastasis, along with the histological subtype of nonsquamous cell carcinoma (OR: 2.84, p = 0.003). However, the incidence of central nervous system (CNS) progression was not associated with PD-L1 positivity, with a two-year cumulative CNS progression rate of 26.3% and 28.4% in PD-L1-positive and PD-L1-negative patients, respectively (log rank p = 0.944). Furthermore, positive PD-L1 expression did not affect CNS progression or overall survival in patients with synchronous brain metastasis (long rank p = 0.513 and 0.592, respectively). Conclusions: Initial brain metastases are common in NSCLC patients with positive PD-L1 expression. Further studies are necessary to understand the relationship between early brain metastasis and cancer immunity.
We investigated the preoperative visual field dependence-independence of 21 VS-patients with the Rod and Frame test and correlated these findings to tumor size, age, gender, and vestibular tests.Results: Seventeen patients had a normal subjective visual horizontal and vertical (SVH-V). These patients showed a significantly increased tilt of the SVH-V when the frame in the Rod and Frame test was tilted toward the lesioned ear (mean, 8.2 degrees), compared to when it was tilted toward the healthy ear (mean, 5.5 degrees) (P Ͻ 0.010). There was no correlation to caloric responses, spontaneous or head shaking nystagmus, or to tumor size and gender.Conclusions: The results indicate that, in spite of a normal subjective visual horizontal and vertical, the extra challenge of the Rod and Frame test can indicate the side of lesion for patients with vestibular schwannoma. This has not been reported earlier and suggests an asymmetric adaptation to the visual surround and a novel mechanism for visio-vestibular conflict and dizziness in patients with vestibular disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.